Join the Network

Interested in becoming a participating site?

Thank you for your interest in the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET). After reviewing the ALZ-NET Protocol Synopsis, please complete the Site Registration and Feasibility Survey by clicking the link below. The 10-minute questionnaire will collect comprehensive information about your site and the population you provide care for. After submission of the questionnaire, the ALZ-NET Operations Team will review all responses and provide you with a decision on your participation in the Network via email. If your site is invited to participate, you will be provided with all essential documents and further instructions on next steps and the start-up process.  For any questions regarding joining the network, email alz-net@acr.org.
 

Site Registration and Feasibility Survey

Site Qualifications for ALZ-NET

The Site Registration and Feasibility questionnaire above will collect data elements from participating sites. Data collected to describe the multi-disciplinary dementia care team include but are not limited to:

• Access to accredited and appropriate radiological services for diagnostic and safety brain imaging
• Access to infusion services
• Access to emergency services
• Access to standard cognitive, behavioral, and functional assessments used in dementia care

Data collected to describe patient population and enrollment feasibility include but are not limited to:

• Race and ethnicity percentages of patient population
• Estimated enrollment capabilities based on the ALZ-NET eligibility criteria

Site Investigator Qualifications for ALZ-NET

• Must hold credentials that authorize prescription of novel FDA-approved therapies.
  • Novel FDA-approved therapies for AD are drugs that have received approval as treatments for Alzheimer's disease (AD) from the U.S. Food and Drug Administration since 2021. 
  • Site Investigator may be a physician, physician assistant, or nurse practitioner.
• All site investigators must have the appropriate education and ability for contact time for evaluation and care of adults with acquired cognitive impairment or dementia.